Reuters logo
BRIEF-GSK says HIV drug Triumeq gets EU marketing approval
September 3, 2014 / 12:30 PM / 3 years ago

BRIEF-GSK says HIV drug Triumeq gets EU marketing approval

Sept 3 (Reuters) - GlaxoSmithKline Plc :

* Triumeq receives EU approval

* ViiV Healthcare receives EU marketing authorisation for Triumeq, a new once-daily single-pill regimen for treatment of HIV Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below